Announcements Trials
Browse Landscape

Status

No longer available 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 260Observational 12Expanded_access 2

Sponsor

Cancer Type

Dermatologic 2CNS 1

Conditions

Melanoma 2

Interventions

trametinib 3dabrafenib 3talimogene laherparepvec 2pembrolizumab 2Nivolumab 2Ipilimumab 2ulixertinib 1tebentafusp 1pegilodecakin 1omaveloxolone 1methyl 5-aminolevulinate 1lifileucel 1efineptakin alfa 1cemiplimab 1balstilimab 1avelumab 1aldesleukin 1Rose Bengal 1Melphalan 1HhAntag691 1Cyclophosphamide 1Brentuximab Vedotin 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Ipilimumab × Dermatologic × Clear all
NCT02186249 2017-02-08

CheckMate218

Bristol-Myers Squibb

No longer available
Dermatologic

Melanoma

NCT00495066 2013-06-03

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Bristol-Myers Squibb

No longer available
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡